Journal of Autoimmunity 2025

3 papers
The 2025 edition of the Journal of Autoimmunity highlights research into the environmental, biochemical, and pharmacological aspects of immune-mediated conditions. A primary area of investigation concerns the relationship between early-life adversity and the subsequent risk of pediatric-onset immune-mediated inflammatory diseases. This research, involving contributors such as Christoffer Sejling and Naja Hulvej Rod, examines how childhood stressors may influence long-term immune system development. Other research directions include the molecular study of psoriasis through the lens of glycobiology and the evaluation of new therapeutic applications for existing medications. Specifically, studies by authors such as Hui Dai and Hong Cai explore the potential of glucagon-like peptide-1 (GLP-1) receptor agonists as disease-modifying agents in autoimmune contexts. These contributions reflect a trend toward identifying novel treatment pathways and understanding the complex interactions between external life events and biological immune responses.

Papers

Title
Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases
Glycobiology of psoriasis: A review
How early-life adversity affects the risk of pediatric-onset immune-mediated inflammatory disease